Oklahoma 2025 Regular Session

Oklahoma Senate Bill SB1064

Introduced
2/3/25  
Refer
2/4/25  

Caption

Health insurance; establishing guidelines for step therapy protocol. Effective date,

Impact

The impact of SB1064 on state laws involves significant modifications to how health insurance providers manage prescription drug coverage. If enacted, it would necessitate that insurers not only follow peer-reviewed guidelines but also provide patients with a means to appeal treatment decisions swiftly, theoretically increasing patient access to necessary medications. Furthermore, by defining terms like 'medical necessity' and establishing strict timelines for exception requests, the bill seeks to protect patients’ rights, ensuring that their healthcare needs are prioritized by insurance companies.

Summary

Senate Bill 1064 aims to regulate step therapy protocols used by health insurance plans in Oklahoma. The legislation mandates that any health insurance plan that employs a step therapy protocol must adhere to established clinical practice guidelines when making treatment decisions. Specifically, plans are required to outline a clear and accessible process for patients and healthcare providers to request exceptions to these protocols. This is critical because it emphasizes the importance of evidence-based decision-making in healthcare, promoting a patient-centered approach in the face of insurance regulations.

Sentiment

The general sentiment around SB1064 appears to be supportive among healthcare providers and patient advocacy groups who argue that it enhances patient care. They believe that the bill's focus on exceptions to step therapy will result in more personalized healthcare solutions. Conversely, there may be apprehensions from insurance providers who could view these regulations as burdensome or as a threat to their ability to manage costs effectively. Overall, the discussions surrounding this bill highlight the ongoing tension between ensuring patient access to necessary treatments while maintaining cost-effectiveness within the healthcare system.

Contention

Notable points of contention regarding SB1064 include concerns about how strictly the bill will be enforced, particularly regarding the timelines established for responding to exception requests. Critics might argue that despite good intentions, the practical implications of enforced guidelines could lead to an increase in operational costs for insurers, potentially affecting premiums or the scope of coverage. Additionally, questions may arise about the actual definitions of terms used within the bill, such as 'medical necessity', which could lead to challenges in implementation and varying interpretations among stakeholders.

Companion Bills

No companion bills found.

Previously Filed As

OK HB1736

Step therapy protocol; defining terms; requiring health benefit plans to implement a new process; exceptions to protocol; information; effective date.

OK HB1736

Step therapy protocol; defining terms; requiring health benefit plans to implement a new process; exceptions to protocol; information; effective date.

OK SB879

Pharmacy benefits managers; requiring publication of data; establishing regulations and compliance measures. Effective date.

OK SB879

Pharmacy benefits managers; requiring publication of data; establishing regulations and compliance measures. Effective date.

OK HB3508

Employee Group Insurance Division; transferring division to the Oklahoma Health Care Authority; effective date; emergency.

OK SB513

Biomarker testing; requiring health insurance coverage of biomarker testing under certain conditions. Effective date.

OK SB513

Biomarker testing; requiring health insurance coverage of biomarker testing under certain conditions. Effective date.

OK HB2853

Health care; creating the Oklahoma Rebate Pass-Through and PBM Meaningful Transparency Act of 2023; definitions; requirements; effective date.

OK HB2853

Health care; creating the Oklahoma Rebate Pass-Through and PBM Meaningful Transparency Act of 2023; definitions; requirements; effective date.

OK HB2748

Public health and safety; step therapy requirements for certain drugs for certain conditions; definitions; authorizing a health benefit plan to allow coverage for prescription drugs for advanced metastatic cancer and associated conditions without proving step therapy; effective date.

Similar Bills

CA AB1998

Opioids: safe prescribing policy.

HI HB216

Relating To Prescription Drugs.

HI SB226

Relating To Prescription Drugs.

NM SB135

Step Therapy Guidelines

NM HB185

Step Therapy Guidelines

NJ A2010

Establishes certain guidelines for health insurance carriers concerning step therapy protocols.

NJ S308

Establishes certain guidelines for health insurance carriers concerning step therapy protocols.

NJ A1825

Establishes certain guidelines for SHBP, SEHBP, and Medicaid concerning step therapy protocols.